Doctors demonstrated a swallowable micro-robot that can be remotely piloted inside the human stomach while the patient ...

In a proof of concept that may reshape the treatment landscape for insulin-dependent diabetes, scientists have demonstrated that human stomach cells can be reprogrammed to secrete insulin—potentially ...

Transplanting human gastric organoids engineered to release insulin in diabetic mice reduced hyperglycemia, offering a therapeutic avenue for type 1 diabetes. Researchers had previously reprogrammed ...

Type 1 diabetes is caused by an insufficient production of the hormone insulin by cells in the pancreas called beta cells and estimated to affect 9.5 million people worldwide. Low insulin levels allow ...

Scientists inch closer to an autologous diabetes cell therapy that dodges the challenge of immune rejection, creating insulin-producing cells from the lining of the gut. As of 2025, an estimated 9.5 ...